BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16552140)

  • 1. Third calcium ion found in an inhibitor-bound phospholipase A2.
    Sekar K; Gayathri D; Velmurugan D; Jeyakanthan J; Yamane T; Poi MJ; Tsai MD
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):392-7. PubMed ID: 16552140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the free and anisic acid bound triple mutant of phospholipase A2.
    Sekar K; Vaijayanthi Mala S; Yogavel M; Velmurugan D; Poi MJ; Vishwanath BS; Gowda TV; Jeyaprakash AA; Tsai MD
    J Mol Biol; 2003 Oct; 333(2):367-76. PubMed ID: 14529623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggestive evidence for the involvement of the second calcium and surface loop in interfacial binding: monoclinic and trigonal crystal structures of a quadruple mutant of phospholipase A2.
    Sekar K; Yogavel M; Kanaujia SP; Sharma A; Velmurugan D; Poi MJ; Dauter Z; Tsai MD
    Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):717-24. PubMed ID: 16790927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation of additional calcium ion in the crystal structure of the triple mutant K56,120,121M of bovine pancreatic phospholipase A2.
    Rajakannan V; Yogavel M; Poi MJ; Jeyaprakash AA; Jeyakanthan J; Velmurugan D; Tsai MD; Sekar K
    J Mol Biol; 2002 Dec; 324(4):755-62. PubMed ID: 12460575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic resolution (0.97 A) structure of the triple mutant (K53,56,121M) of bovine pancreatic phospholipase A2.
    Sekar K; Rajakannan V; Gayathri D; Velmurugan D; Poi MJ; Dauter M; Dauter Z; Tsai MD
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Jan; 61(Pt 1):3-7. PubMed ID: 16508077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into metal ion binding in phospholipases A2: ultra high-resolution crystal structures of an acidic phospholipase A2 in the Ca2+ free and bound states.
    Murakami MT; Gabdoulkhakov A; Genov N; Cintra AC; Betzel C; Arni RK
    Biochimie; 2006 May; 88(5):543-9. PubMed ID: 16376474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the complex of bovine pancreatic phospholipase A2 with the inhibitor 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol,
    Sekar K; Eswaramoorthy S; Jain MK; Sundaralingam M
    Biochemistry; 1997 Nov; 36(46):14186-91. PubMed ID: 9369492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomic resolution structure of the double mutant (K53,56M) of bovine pancreatic phospholipase A2.
    Sekar K; Yogavel M; Gayathri D; Velmurugan D; Krishna R; Poi MJ; Dauter Z; Dauter M; Tsai MD
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jan; 62(Pt 1):1-5. PubMed ID: 16511247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
    Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution refinement of orthorhombic bovine pancreatic phospholipase A2.
    Sekar K; Sundaralingam M
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):46-50. PubMed ID: 10089393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures and molecular-dynamics studies of three active-site mutants of bovine pancreatic phospholipase A(2).
    Kanaujia SP; Sekar K
    Acta Crystallogr D Biol Crystallogr; 2008 Oct; 64(Pt 10):1003-11. PubMed ID: 18931407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the Y52F/Y73F double mutant of phospholipase A2: increased hydrophobic interactions of the phenyl groups compensate for the disrupted hydrogen bonds of the tyrosines.
    Sekharudu C; Ramakrishnan B; Huang B; Jiang RT; Dupureur CM; Tsai MD; Sundaralingam M
    Protein Sci; 1992 Dec; 1(12):1585-94. PubMed ID: 1304890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural biology of recombinant bovine pancreatic phospholipase A2 and its inhibitor complexes.
    Sekar K
    Curr Top Med Chem; 2007; 7(8):779-85. PubMed ID: 17456041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, function and interfacial allosterism in phospholipase A2: insight from the anion-assisted dimer.
    Bahnson BJ
    Arch Biochem Biophys; 2005 Jan; 433(1):96-106. PubMed ID: 15581569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of the H48Q active site mutant of human group IIA secreted phospholipase A2 at 1.5 A resolution provides an insight into the catalytic mechanism.
    Edwards SH; Thompson D; Baker SF; Wood SP; Wilton DC
    Biochemistry; 2002 Dec; 41(52):15468-76. PubMed ID: 12501175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A redetermination of the structure of the triple mutant (K53,56,120M) of phospholipase A2 at 1.6 A resolution using sulfur-SAS at 1.54 A wavelength.
    Sekar K; Rajakannan V; Velmurugan D; Yamane T; Thirumurugan R; Dauter M; Dauter Z
    Acta Crystallogr D Biol Crystallogr; 2004 Sep; 60(Pt 9):1586-90. PubMed ID: 15333929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural determinant of the unique interfacial binding mode of bovine pancreatic phospholipase A2.
    Lee BI; Dua R; Cho W
    Biochemistry; 1999 Jun; 38(24):7811-8. PubMed ID: 10387021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase A2 engineering. Deletion of the C-terminus segment changes substrate specificity and uncouples calcium and substrate binding at the zwitterionic interface.
    Huang B; Yu BZ; Rogers J; Byeon IJ; Sekar K; Chen X; Sundaralingam M; Tsai MD; Jain MK
    Biochemistry; 1996 Sep; 35(37):12164-74. PubMed ID: 8810924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structure of bovine pancreatic phospholipase A2 at atomic resolution.
    Steiner RA; Rozeboom HJ; de Vries A; Kalk KH; Murshudov GN; Wilson KS; Dijkstra BW
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):516-26. PubMed ID: 11264580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive.
    Pan YH; Yu BZ; Berg OG; Jain MK; Bahnson BJ
    Biochemistry; 2002 Dec; 41(50):14790-800. PubMed ID: 12475227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.